Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Does the Sell-Off of BioNTech and Moderna Stocks Present a Buying Opportunity?

TheMotleyFool

0 0

Does the Sell-Off of BioNTech and Moderna Stocks Present a Buying Opportunity?

For much of this year, BioNTech (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) stocks have soared. But shares of both vaccine makers sank on Friday, with the negative momentum carrying over into this week.

Blame it on Merck (NYSE: MRK). The big drugmaker and its small partner, Ridgeback Biotherapeutics, announced stellar results on Friday from a late-stage study of an oral COVID-19 therapy, molnupiravir.

Several of the leading vaccine stocks tumbled on Merck and Ridgeback's positive data. But does the sell-off of BioNTech and Moderna stocks present a great buying opportunity?

Source Fool.com

Like: 0

MRNA

Share